tiprankstipranks
Advertisement
Advertisement

RDY Stock Latest News

Dr. Reddy’s Allots Equity Shares Under ESOP on March 26, 2026
Company AnnouncementsDr. Reddy’s Allots Equity Shares Under ESOP on March 26, 2026
2d ago
6K
RDY
Dr. Reddy’s Tightens Insider-Information Disclosure Code After Board Approval
PremiumCompany Announcements
Dr. Reddy’s Tightens Insider-Information Disclosure Code After Board Approval
4d ago
6K
RDY
Dr. Reddy’s Schedules May 12 Board Meeting to Approve FY 2026 Results, Closes Trading Window
PremiumCompany Announcements
Dr. Reddy’s Schedules May 12 Board Meeting to Approve FY 2026 Results, Closes Trading Window
5d ago
6K
RDY
Dr. Reddy’s Launches India’s First DCGI-Approved Generic Semaglutide Obeda for Type 2 Diabetes
PremiumCompany Announcements
Dr. Reddy’s Launches India’s First DCGI-Approved Generic Semaglutide Obeda for Type 2 Diabetes
5d ago
6K
RDY
Dr. Reddy’s Faces GST Penalty Orders for FY 2019–22, Sees No Material Impact
PremiumCompany Announcements
Dr. Reddy’s Faces GST Penalty Orders for FY 2019–22, Sees No Material Impact
11d ago
6K
RDY
Dr. Reddy’s Flags Phase III Setback as Immutep Halts Key Lung Cancer Trial
PremiumCompany AnnouncementsDr. Reddy’s Flags Phase III Setback as Immutep Halts Key Lung Cancer Trial
15d ago
6K
RDY
Dr. Reddy’s Allots New ESOP Shares, Slightly Increases Equity Capital
Premium
Company Announcements
Dr. Reddy’s Allots New ESOP Shares, Slightly Increases Equity Capital
16d ago
6K
RDY
Dr. Reddy’s Cleared by Delhi High Court to Export Semaglutide to Non-Patent Markets
Premium
Company Announcements
Dr. Reddy’s Cleared by Delhi High Court to Export Semaglutide to Non-Patent Markets
16d ago
6K
RDY
Dr. Reddy’s Cleared as U.S. DOJ Closes FCPA Inquiry Without Enforcement
PremiumCompany Announcements
Dr. Reddy’s Cleared as U.S. DOJ Closes FCPA Inquiry Without Enforcement
22d ago
6K
RDY
Dr. Reddy’s Schedules Analyst and Investor Meets for Early March 2026
PremiumCompany Announcements
Dr. Reddy’s Schedules Analyst and Investor Meets for Early March 2026
29d ago
6K
RDY
Dr. Reddy’s Says SEC Ends FCPA Probe Without Recommending Enforcement Action
PremiumCompany Announcements
Dr. Reddy’s Says SEC Ends FCPA Probe Without Recommending Enforcement Action
1M ago
6K
RDY
Dr. Reddy’s reports FDA acceptance to review Abatacept BLA
PremiumThe Fly
Dr. Reddy’s reports FDA acceptance to review Abatacept BLA
1M ago
RDY
Dr. Reddy’s Buys Progynova HRT Brands in India to Bolster Gynecology Portfolio
PremiumCompany AnnouncementsDr. Reddy’s Buys Progynova HRT Brands in India to Bolster Gynecology Portfolio
1M ago
6K
RDY
Dr. Reddy’s Allots 12,665 ESOP Shares, Nudging Up Equity Capital
Premium
Company Announcements
Dr. Reddy’s Allots 12,665 ESOP Shares, Nudging Up Equity Capital
1M ago
6K
RDY
Dr. Reddy’s Schedules Mumbai Investor Meet for February 23, 2026
Premium
Company Announcements
Dr. Reddy’s Schedules Mumbai Investor Meet for February 23, 2026
1M ago
6K
RDY
Dr. Reddy’s Announces May Exit of Global Head of IPDO Sushrut Kulkarni
PremiumCompany Announcements
Dr. Reddy’s Announces May Exit of Global Head of IPDO Sushrut Kulkarni
2M ago
6K
RDY
Dr. Reddy’s Schedules Nuvama Investor Conference Meetings in Mumbai on February 9, 2026
PremiumCompany Announcements
Dr. Reddy’s Schedules Nuvama Investor Conference Meetings in Mumbai on February 9, 2026
2M ago
6K
RDY
Coya Therapeutics to sell 2.522M shares at $4.40 in private placement
PremiumThe Fly
Coya Therapeutics to sell 2.522M shares at $4.40 in private placement
2M ago
RDY
COYA
Dr. Reddy’s Q3 Earnings Call: Growth Amid Margin Strain
PremiumCompany Announcements
Dr. Reddy’s Q3 Earnings Call: Growth Amid Margin Strain
2M ago
RDY
Dr. Reddy’s Russian Subsidiary Faces VAT Reclassification Penalty Deemed Immaterial
PremiumCompany AnnouncementsDr. Reddy’s Russian Subsidiary Faces VAT Reclassification Penalty Deemed Immaterial
2M ago
6K
RDY
Is RDY a Buy, Before Earnings?
Premium
Pre-Earnings
Is RDY a Buy, Before Earnings?
2M ago
RDY
Dr. Reddy’s Launches First-to-Market Generic of Extra-Strength Pataday in U.S. OTC Eye-Care Segment
Premium
Company Announcements
Dr. Reddy’s Launches First-to-Market Generic of Extra-Strength Pataday in U.S. OTC Eye-Care Segment
2M ago
6K
RDY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >